mctw21-photos

• 
  Opening remarks - Roman Hájek and Michal Šimiček
• 
  Opening remarks - Roman Hájek and Michal Šimiček
• 
  Opening remarks - Roman Hájek and Michal Šimiček
• 
  SESSION I chair: Tereza Ševčíková
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Q&A SESSION I
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Q&A SESSION I
• 
  Da Via` Matteo Claudio, University of Milan, Italy
• 
  Q&A SESSION I
• 
  SESSION I
• 
  SESSION I
• 
  Bruno Paiva, Center for Applied Medical Research, Spain
• 
  Bruno Paiva, Center for Applied Medical Research, Spain
• 
  Q&A SESSION I
• 
  Despina Bazou, Mater Misericordiae University Hospital, Ireland
• 
  MCTW21
• 
  Q&A SESSION I
• 
  Q&A SESSION I
• 
  MCTW21
• 
  MCTW21
• 
  MCTW21
• 
  MCTW21
• 
  MCTW21
• 
  MCTW21
• 
  SESSION II chair: Zuzana Chyra
• 
  Tom Cupedo, Erasmus MC Rotterdam, Netherlands
• 
  Tom Cupedo, Erasmus MC Rotterdam, Netherlands
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  Eline Menu, VUB Brussels, Belgium
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  Cirino Botta, University of Palermo, Italy
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  Q&A SESSION II
• 
  SESSION III chair: Tomáš Jelínek
• 
  Tereza Sevcikova, Blood Cancer Research Group, Czech Republic
• 
  Tereza Sevcikova, Blood Cancer Research Group, Czech Republic
• 
  Q&A SESSION III
• 
  Q&A SESSION III
• 
  Luciano Costa - University of Alabama at Birmingham
• 
  Q&A SESSION III
• 
  MCTW21
• 
  Francesco Maura, Sylvester Comprehensive Cancer Center, University of Miami, USA
• 
  MCTW21
• 
  Morie Gertz, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA
• 
  Q&A SESSION III
• 
  MCTW21
• 
  MCTW21
• 
  SESSION IV chair: Michal Šimíček
• 
  Caroline Heckman, Institute for Molecular Medicine Finland, Finland
• 
  Caroline Heckman, Institute for Molecular Medicine Finland, Finland
• 
  Q&A SESSION IV
• 
  Q&A SESSION IV
• 
  Tomas Jelinek, Blood Cancer Research Group, Ostrava, Czech Republic
• 
  Tomas Jelinek, Blood Cancer Research Group, Ostrava, Czech Republic
• 
  MCTW21
• 
  MCTW21
• 
  MCTW21
• 
  Q&A SESSION IV
• 
  Marcello Turi, Blood Cancer Research Group, Czech Republic
• 
  Marcello Turi, Blood Cancer Research Group, Czech Republic
• 
  Q&A SESSION IV
• 
  SESSION V chair: Hana Šahinbegović
• 
  Michael Hudecek, University of Würzburg, Germany
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Monika Holubová, Fakultní nemocnice Plzeň, , Czech Republic
• 
  Monika Holubová, Fakultní nemocnice Plzeň, , Czech Republic
• 
  Q&A SESSION V
• 
  Leo Rasche, Universty of Würzburg, Germany
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  MCTW21
• 
  Sophia Adamia, Dana-Farber Cancer Institute, USA
• 
  Q&A SESSION V
• 
  Q&A SESSION V
• 
  Kenneth Anderson, Dana-Farber Cancer Institute, USA
• 
  SPECIAL SESSION chair: Michal Šimíček
• 
  Q&A SPECIAL SESSION
• 
  Q&A SPECIAL SESSION
• 
  Q&A SPECIAL SESSION
• 
  Q&A SPECIAL SESSION
• 
  Q&A SPECIAL SESSION
• 
  SESSION VI chair: Matouš Hrdinka
• 
  Michal Smida, Citec, Czech Republic
• 
  Michal Smida, Citec, Czech Republic
• 
  Q&A SESSION VI
• 
  Q&A SESSION VI
• 
  Q&A SESSION VI
• 
  Piotr Celichowski, Blood Cancer Research Group, Ostrava, Czech Republic
• 
  Piotr Celichowski, Blood Cancer Research Group, Ostrava, Czech Republic
• 
  Piotr Celichowski, Blood Cancer Research Group, Ostrava, Czech Republic
• 
  Q&A SESSION VI
• 
  Q&A SESSION VI
• 
  Michael O`Dwyer, National University of Ireland, Ireland
• 
  Closing remarks